Top Markets
#1 Derive Derive +15.92%
#2 Cross Cross +14.63%
#3 Glidr Glidr +10.10%
#4 Gama Token Gama Token +9.10%
#5 Based Based +5.46%
#6 Talus Network Talus Network +5.41%
#7 龙虾 (Lobster) 龙虾 (Lobster) +4.95%
#8 Cap Cap +4.91%
#9 TDCCP TDCCP +4.76%
#10 LEO Token LEO Token +4.69%
Coin of the day
Derive Derive
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Accustem Sciences Inc. Accustem Sciences Inc.

Accustem Sciences Inc.

ACUT
Rang in Aktien #36602
AccuStem Sciences, Inc. operates as a life science firm committed to improving... AccuStem Sciences, Inc. operates as a life science firm committed to improving the outlook for individuals battling cancer. Its primary innovation is the StemPrintER technology, an advanced multi-gene prognostic assay designed to predict the likelihood of recurrence for patients with Endocrine receptor-positive /HER2- breast cancer. The company also offers Spare, a related diagnostic tool that expands upon StemPrintER by incorporating two additional clinical markers. AccuStem Sciences, Inc. is based in New York, New York.
Aktienkurs
$0.156
Zuletzt synchronisiert: 2026-08-13
Marktkapitalisierung
$2.51M
Veränderung (1 Tag)
2.97%
Veränderung (1 Jahr)
-91.28%
Land
US
Handel Accustem Sciences Inc. (ACUT)

Kategorie

Healthcare
Dividendenrendite-Verlauf für Accustem Sciences Inc. (ACUT)
Dividendenrendite (TTM) von Accustem Sciences Inc. (Aktienkürzel: ACUT) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Accustem Sciences Inc. (ACUT) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
0.48%
BE